SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell CarcinomaOA
Objective:The systematic evaluation of expansive genomic databases facilitates the discovery of clinically vital biomarkers.While Sideroflexin 3(SFXN3)consistently displays elevated expression in head and neck squamous cell carcinoma(HNSCC),its specific pathobiological functions and prognostic value remain insufficiently characterized.This study aims to delineate the clinical and functional significance of SFXN3 in HNSCC.Methods:We interrogated SFXN3 expression patterns,patient survival outcomes,and immune cell infiltration characteristics utilizing multiple independent repositories,including the cancer genome atlas(TCGA)and gene expression omnibus(GEO).The prognostic independence of SFXN3 was verified via multivariate Cox regression.These computational findings were subsequently corroborated through targeted in vitro functional assays.Results:SFXN3 expression was significantly augmented in HNSCC,demonstrating strong correlations with advanced disease stages and reduced overall survival.Multivariate models confirmed its status as an independent prognostic indicator.Furthermore,SFXN3 upregulation was closely tied to an immunosuppressive microenvironment.In vitro validations revealed that SFXN3 knockdown substantially impairs cell proliferation while simultaneously sensitizing HNSCC cells to cisplatin-induced apoptosis via intrinsic pathways.Conclusion:Ultimately,SFXN3 represents a robust prognostic indicator and an actionable therapeutic vulnerability to counteract both drug resistance and tumor immune escape in HNSCC.
Eun-Jeong Jeong;Yeon Soo Kim;Yujin Lee;Jae-Sung Ryu;Yung Hyun Choi;Eunjeong Kim
Department of Otorhinolaryngology–Head and Neck Surgery,College of Medicine,Konyang University,Daejeon,Republic of Korea Department of Otorhinolaryngology–Head and Neck Surgery,College of Medicine,Korea University,Seoul,Republic of KoreaDepartment of Otorhinolaryngology–Head and Neck Surgery,College of Medicine,Korea University,Seoul,Republic of KoreaBK21 FOUR KNU Creative BioResearch Group,Department of Biology,College of Natural Sciences,Kyungpook National University,Daegu,Republic of KoreaNew Drug Development Center,Osong Medical Innovation Foundation,Cheongju,Republic of KoreaBasic Research Laboratory for the Regulation of Microplastic-Mediated Diseases and Anti-Aging Research Center,Dong-eui University,Busan,Republic of Korea Department of Biochemistry,College of Korean Medicine,Dong-eui University,Busan,Republic of KoreaBK21 FOUR KNU Creative BioResearch Group,Department of Biology,College of Natural Sciences,Kyungpook National University,Daegu,Republic of Korea Center for Genome Engineering,Institute for Basic Science,Daejeon,Republic of Korea
医药卫生
Sideroflexin 3(SFXN3)head and neck squamous cell carcinoma(HNSCC)bioinformaticsThe Cancer Genome Atlas(TCGA)biomarkerprognosistumor microenvironment
《Oncology Research》 2026 (6)
P.539-562,24
supported by the National Research Foundation of Korea(NRF)grant,funded by the Korean government(MSIT)(Grant Numbers:RS-2023-00217899 and RS-2024-00453724)This research was supported by Basic Science Research Program through the National Research Foundation of Korea(NRF)funded by the Ministry of Education RS-2025-25437414.
评论